Back

Comparison of cardiovascular and metabolic profiles in lorlatinib vs. other ALK inhibitors in global network

29 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Refining cardiotoxicity risk in cardio-oncology Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Szu-Han Wang

Tainan Hospital, Tainan (Taiwan)

5 More presentations in this session

Presentation thumbnail
Risk factors and comorbidities of immune checkpoint inhibitor-associated myocarditis
Miss T. Paul (New Orleans, US)
Abstract
Presentation thumbnail
Timing of sacubitril/valsartan initiation and cardiovascular outcomes in anthracycline-treated cancer patients
Doctor I. Figueroa Baez (San Juan, PR)
Abstract
Presentation thumbnail
Sex differences in cardiovascular outcomes with sacubitril/valsartan in anthracycline-treated cancer patients
Doctor L. Cruz (Santiago de los Caballeros, DO)
Abstract
Presentation thumbnail
Clinical predictors of cardiotoxicity in a large cardio-oncology cohort: a caribbean registry analysis
Doctor L. Cruz (Santiago de los Caballeros, DO)
Abstract
Presentation thumbnail
Cardioprotective effects of sacubitril/valsartan according to baseline cardiovascular risk during adjuvant breast cancer therapy: a randomized placebo-controlled trial
Mrs M. Gynnild (Trondheim, NO)
Abstract

Access the full session

Session thumbnail
Refining cardiotoxicity risk in cardio-oncology

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparative effectiveness of novel anti-hyperlipidemic drugs in adults with hyperlipidemia: a systematic review and bayesian network meta-analysis
4 April 2025
thumbnail
Congress Presentation
Direct effects of the tyrosine kinase inhibitors (TKIs) nilotinib and imatinib on the myocardium: clues towards cardiotoxic profiles
20 June 2025
thumbnail
Congress Presentation
Low lipid levels and high variability correlate with the risk of new-onset atrial fibrillation
1 September 2019
thumbnail
Congress Presentation
A young patient with stage IV lung cancer and cardiac endocavitary metastasis: A case report.
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources